These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37740714)

  • 41. Disability in progressive MS is associated with T2 lesion changes.
    Ammitzbøll C; Dyrby TB; Lyksborg M; Schreiber K; Ratzer R; Romme Christensen J; Iversen P; Magyari M; Garde E; Sørensen PS; Siebner HR; Sellebjerg F
    Mult Scler Relat Disord; 2018 Feb; 20():73-77. PubMed ID: 29324249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic Resonance Imaging in Primary Progressive Multiple Sclerosis Patients : Review.
    Siger M
    Clin Neuroradiol; 2022 Sep; 32(3):625-641. PubMed ID: 35258820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis.
    Cortese R; Tur C; Prados F; Schneider T; Kanber B; Moccia M; Wheeler-Kingshott CAG; Thompson AJ; Barkhof F; Ciccarelli O
    Mult Scler; 2021 Jan; 27(1):28-38. PubMed ID: 31961242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
    Absinta M; Vuolo L; Rao A; Nair G; Sati P; Cortese IC; Ohayon J; Fenton K; Reyes-Mantilla MI; Maric D; Calabresi PA; Butman JA; Pardo CA; Reich DS
    Neurology; 2015 Jul; 85(1):18-28. PubMed ID: 25888557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional Disability and Brain MRI Volumetry Results among Multiple Sclerosis Patients during 5-Year Follow-Up.
    Strautmane S; Balodis A; Teivane A; Grabovska D; Naudins E; Urbanovics D; Fisermans E; Mednieks J; Flintere-Flinte A; Priede Z; Millers A; Zolovs M
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374286
    [No Abstract]   [Full Text] [Related]  

  • 49. Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosis.
    Carotenuto A; Signoriello E; Lanzillo R; Vaia Y; Moccia M; Bonavita S; Lus G; Brescia Morra V
    Mult Scler Relat Disord; 2020 Aug; 43():102211. PubMed ID: 32474285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters.
    Minneboo A; Jasperse B; Barkhof F; Uitdehaag BM; Knol DL; de Groot V; Polman CH; Castelijns JA
    J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):917-23. PubMed ID: 18077480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis.
    Bonacchi R; Pagani E; Meani A; Cacciaguerra L; Preziosa P; De Meo E; Filippi M; Rocca MA
    Radiology; 2020 Sep; 296(3):605-615. PubMed ID: 32573387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis.
    Calvi A; Carrasco FP; Tur C; Chard DT; Stutters J; De Angelis F; John N; Williams T; Doshi A; Samson RS; MacManus D; Gandini Wheeler-Kingshott CA; Ciccarelli O; Chataway J; Barkhof F;
    Neurology; 2022 Apr; 98(17):e1783-e1793. PubMed ID: 35277438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain atrophy and lesion load predict long term disability in multiple sclerosis.
    Popescu V; Agosta F; Hulst HE; Sluimer IC; Knol DL; Sormani MP; Enzinger C; Ropele S; Alonso J; Sastre-Garriga J; Rovira A; Montalban X; Bodini B; Ciccarelli O; Khaleeli Z; Chard DT; Matthews L; Palace J; Giorgio A; De Stefano N; Eisele P; Gass A; Polman CH; Uitdehaag BM; Messina MJ; Comi G; Filippi M; Barkhof F; Vrenken H;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1082-91. PubMed ID: 23524331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study.
    Barnett M; Bergsland N; Weinstock-Guttman B; Butzkueven H; Kalincik T; Desmond P; Gaillard F; van Pesch V; Ozakbas S; Rojas JI; Boz C; Altintas A; Wang C; Dwyer MG; Yang S; Jakimovski D; Kyle K; Ramasamy DP; Zivadinov R
    Neuroimage Clin; 2021; 32():102802. PubMed ID: 34469848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Network Damage Predicts Clinical Worsening in Multiple Sclerosis: A 6.4-Year Study.
    Rocca MA; Valsasina P; Meani A; Pagani E; Cordani C; Cervellin C; Filippi M
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34021055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI.
    Fuchs TA; Dwyer MG; Jakimovski D; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Hb Benedict R; Zivadinov R
    Neuroimage Clin; 2021; 31():102705. PubMed ID: 34091352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
    Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.
    Sastre-Garriga J; Ingle GT; Chard DT; Cercignani M; Ramió-Torrentà L; Miller DH; Thompson AJ
    Brain; 2005 Jun; 128(Pt 6):1454-60. PubMed ID: 15817511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.